seed
Stage
2
Investors
About
Amplio Pharma develops modified retention technology to enhance the efficacy and safety of existing drugs, particularly focusing on improving the treatment of autoimmune diseases like rheumatoid arthritis through its NovoBioJect product.
Explore Amplio Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.